1. Home
  2. KRNT vs FDMT Comparison

KRNT vs FDMT Comparison

Compare KRNT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kornit Digital Ltd.

KRNT

Kornit Digital Ltd.

N/A

Current Price

$16.80

Market Cap

728.7M

Sector

Industrials

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$12.41

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRNT
FDMT
Founded
2002
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
728.7M
695.3M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
KRNT
FDMT
Price
$16.80
$12.41
Analyst Decision
Buy
Strong Buy
Analyst Count
5
12
Target Price
$25.00
★ $28.09
AVG Volume (30 Days)
315.0K
★ 933.5K
Earning Date
11-18-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.79
EPS
★ N/A
N/A
Revenue
N/A
★ $85,209,000.00
Revenue This Year
$7.48
N/A
Revenue Next Year
$7.27
$55.65
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$12.26
$6.96
52 Week High
$19.78
$16.93

Technical Indicators

Market Signals
Indicator
KRNT
FDMT
Relative Strength Index (RSI) 44.42 48.92
Support Level $14.56 $8.68
Resistance Level $16.80 $13.64
Average True Range (ATR) 0.68 1.02
MACD -0.19 0.05
Stochastic Oscillator 30.20 58.89

Price Performance

Historical Comparison
KRNT
FDMT

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd is a developer and provider of digital solutions for the printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software, and value-added services that enable large-scale printing of short-run complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink, and other consumables, and services, including software subscriptions. The company geographically operates in the U.S., EMEA, Asia Pacific, and other countries. It derives maximum revenue from the U.S.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: